The 11th NCI EDRN Scientific Workshop to be held in Bethesda North Marriott Hotel from September 9 through September 12, 2019. NCI's Early Detection Research Network (EDRN) is a consortium of investigators committed to translational research on cancer biomarkers and their clinical application. The main goals of the consortium are to enable population cancer screening, detection of cancers at an early stage, and ultimately reduction in morbidity and mortality. Major efforts are devoted to developing and validating cancer biomarkers and to creating the infrastructure necessary for their clinical validation.
This year's event entitled, "Next Generation of Biomarkers” will include both lectures and panel discussions. The topics of the workshop include standards and regulatory science, novel technologies for precision detection, imaging, clinical and validation science, and collaboration with other alliances and consortia on biomarkers.
- Biomarkers and Regulatory Science
- Imaging, Radiomics and Biomarkers
- Multimodal Screening
- Organ-Specific Updates and Companion Diagnostics
- Epigenetics, Proteomics, Glycomics, Metabolomics and Other Markers
- In Silico Biomarker Discovery
- AI and BIG Data
Individuals with disabilities who need Sign Language Interpreters and/or reasonable accommodation to participate in this event should contact Felicia Evans Long, email@example.com, 240-276-5076, and/or the Federal Relay Service (1-800-877-8339). Requests should be made at least two business days in advance of the event.